TipRanks
TipRanksTop Financial ExpertsInsidersClaire Fraser-Liggett

Claire Fraser-Liggett Insider Profile

4 Followers
Claire Fraser-Liggett, Director at Seres Therapeutics, holds ― shares in Seres Therapeutics (Ticker: MCRB), holds 489.00 shares in Waters (Ticker: WAT), holds 22.23K shares in Becton Dickinson (Ticker: BDX). Most recently, Claire Fraser-Liggett ― shares of Seres Therapeutics on ― for an estimated value of ―.
See the Hottest Stocks Based on Insider Trading >
tipranks
Claire Fraser-Liggett

Claire Fraser-Liggett
Seres Therapeutics (MCRB)
Director

Ranked #68,319 out of 109,232 Corporate Insiders

Profitable Transactions

33%
3 out of 9 Profitable Transactions

Average Return

-5.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$4M
94.97%
5.03%
0.00%
A breakdown of Claire Fraser-Liggett's holdings
See the Top Stocks by Insiders

Insider Roles

Becton Dickinson
(BDX)
Director
Waters
(WAT)
Director
Seres Therapeutics
(MCRB)
Director
Roles that Claire Fraser-Liggett holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Becton Dickinson
(BDX)
Rating:Informative Sell
Date:Aug 30, 2023 - Aug 30, 2024
Return:+12.10%
The most profitable trade made by Claire Fraser-Liggett
See the Latest Stocks Traded by Insiders

Claire Fraser-Liggett's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MCRB
Seres Therapeutics
―
Director
―
―
WAT
Waters
Feb 27, 2026
Director
Uninformative Buy
―
$207.93K
BDX
Becton Dickinson
Sep 11, 2025
Director
Informative Sell
171.94K
$3.93M
List of latest transactions for each holding click on a transaction to see Claire Fraser-Liggett's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Claire Fraser-Liggett insider profile FAQ

What is the percentage of profitable transactions made by Claire Fraser-Liggett?
The percentage of profitable transactions made by Claire Fraser-Liggett is 33%.
    What is the average return per transaction made by Claire Fraser-Liggett?
    The average return per transaction made by Claire Fraser-Liggett is -5.00%.
      What stocks does Claire Fraser-Liggett hold?
      Claire Fraser-Liggett holds: MCRB, WAT, BDX stocks.
        What was Claire Fraser-Liggett’s latest transaction?
        Claire Fraser-Liggett latest transaction was an Uninformative Buy of ―.
          What was Claire Fraser-Liggett's most profitable transaction?
          Claire Fraser-Liggett’s most profitable transaction was an Informative Sell of BDX stock on August 30, 2023. The return on the trade was 12.10%.
            What is Claire Fraser-Liggett's role in Seres Therapeutics?
            Claire Fraser-Liggett's role in Seres Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.